Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Grossmann, Katja Dr. (1) Leutz, Achim Prof. Dr. (1) Mathas, Stephan Dr. (13) Rajewsky, Nikolaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (15) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (11) (-) Lusatis, Simone (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) 2004 (2) (-) 2005 (2) (-) 2006 (4) 2007 (2) (-) 2008 (2) (-) 2009 (5) 2010 (1) 2011 (5) 2012 (2) 2013 (2) 2014 (3) 2015 (3) 2016 (2) 2017 (4) 2018 (1) 2020 (4) 2021 (4) 2022 (4) 2023 (6) 2024 (1) (-) Biology of Malignant Lymphomas (11) Genetics and Genomics of Cardiovascular Diseases (1) Intracellular Proteolysis (1) Molecular Immunology and Gene Therapy (1) Protein Production and Characterization (1) (-) Proteome Dynamics (2) 13 Results: Active Filter: Janz, Martin Dr.Lusatis, SimoneBiology of Malignant LymphomasProteome Dynamics2005200620082009 Sort: Result score Newest to oldest Oldest to newest January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou October 29, 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch September 01, 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz May 21, 2009 / Genome Med Novel insights into proteomic technologies and their clinical perspective G. Dittmar M. Selbach October 15, 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
October 29, 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
September 01, 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
May 21, 2009 / Genome Med Novel insights into proteomic technologies and their clinical perspective G. Dittmar M. Selbach
October 15, 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas